Latest Articles
FDA Approves Promega OncoMate® MSI Dx as Companion Diagnostic for KEYTRUDA® and LENVIMA® in Endometrial Cancer - Voice Of HealthCare
FDA Approves Promega OncoMate® MSI Dx as Companion Diagnostic for KEYTRUDA® and LENVIMA® in Endometrial Cancer Voice Of HealthCare
Published: Nov. 13, 2025, 6:17 a.m.
FDA Approves Diagnostic Tool for Pembrolizumab Combo in Endometrial Cancer - CancerNetwork
FDA Approves Diagnostic Tool for Pembrolizumab Combo in Endometrial Cancer CancerNetwork
Published: Nov. 12, 2025, 7:12 p.m.
Sylvester Comprehensive Cancer Center Launches Clinical Trial on Fasting for Endometrial Cancer - University of Miami
Sylvester Comprehensive Cancer Center Launches Clinical Trial on Fasting for Endometrial Cancer University of Miami
Published: Nov. 12, 2025, 1:59 p.m.
Mathematical model of optimal control for endometrial cancer with treatments dostarlimab and chemotherapy using Caputo derivative - Nature
Mathematical model of optimal control for endometrial cancer with treatments dostarlimab and chemotherapy using Caputo derivative Nature
Published: Nov. 11, 2025, 8:42 p.m.
'It took a year to get diagnosed with cancer because the doctor missed one symptom' - Daily Express US
'It took a year to get diagnosed with cancer because the doctor missed one symptom' Daily Express US
Published: Nov. 11, 2025, 4:56 p.m.
Development of a senescence-related lncRNA signature in endometrial cancer based on multiple machine learning models - Frontiers
Development of a senescence-related lncRNA signature in endometrial cancer based on multiple machine learning models Frontiers
Published: Nov. 11, 2025, 4:15 p.m.
TCGA molecular subtypes in endometriosis-associated ovarian cancer: a systematic review and meta-analysis.
Endometriosis-associated ovarian cancer (EAOC) mainly includes endometrioid ovarian cancer (ENOC) and clear cell ovarian cancer (CCOC). The Cancer Genome Atlas (TCGA) revealed four molecular subtypes of endometrial cancer (EC) in …
Published: Nov. 11, 2025, midnight
Adverse Event and Quality-of-Life Considerations in Endometrial Cancer - OncLive
Adverse Event and Quality-of-Life Considerations in Endometrial Cancer OncLive
Published: Nov. 10, 2025, 1:37 p.m.
Bar Levy: Endometrial Cancer Must Be Prioritized in Global Health Policy - Oncodaily
Bar Levy: Endometrial Cancer Must Be Prioritized in Global Health Policy Oncodaily
Published: Nov. 10, 2025, 11:06 a.m.
Endometrial cancer treatment market to see ‘significant’ growth by 2034: report - Healthcare Asia Magazine
Endometrial cancer treatment market to see ‘significant’ growth by 2034: report Healthcare Asia Magazine
Published: Nov. 10, 2025, 2:56 a.m.
Link copied to clipboard!